February 6, 2012
The American Pharmacists Association has tapped Mary Roederer, PharmD, as the section adviser for the new “Pharmacogenomics Corner,” a new section of the APhA DrugInfoLine newsletter.
“Pharmacogenomics Corner” will provide practicing pharmacists with interpretative summaries of newly published clinical articles in the field of pharmacogenomics and pharmacogenetics. With the Drug Interactions Corner, the Pharmacogenomics Corner is accessed through the Personalized Care button on the ADIL website, aphadruginfoline.com, and Apple app.
As a section adviser, Roederer will suggest topics for coverage, review articles for accuracy and relevance, provide feedback and advice about the APhA DrugInfoLine, and serve as an ambassador for the newsletter and the profession.
Roederer is a research assistant professor and member of the School’s Institute for Pharmacogenomics and Individualized Therapy and a clinical assistant professor in the Department of Family Medicine in the UNC School of Medicine. She is also the chief therapeutics officer for the Pharmacogenetics for Every Nation Initiative. She earned a PharmD from the School and completed a pharmacotherapy residency in family medicine at East Carolina University’s Brody School of Medicine. She is a board certified pharmacotherapy specialist.
Launched in 2000 as a monthly print newsletter, the APhA DrugInfoLine is now a continuously updated digital service providing drug news information to APhA members. At www.APhADrugInfoLine.com, readers can access expert-vetted summaries of virtually any major clinical study or guideline published since 2000. Important FDA approvals, alerts, recalls or market withdrawals are generally posted within twelve hours of announcement, and Twitter feeds notify followers of new articles (@druginfoline) and FDA alerts (@medicationmon).
Latest News
RASP poster presentations capture student research
Delesha Carpenter promoted to full professor
